Hyderabad, 29 July: Hetero group laga part, Hetero Labs para Wednesday din India te brand naam ‘Favivir’ pithor te generic Favipiravir suru kora khobor janaishe.
City-based drug maker, Hetero para release deya hisaab te, Hetero ke Favipiravir bonabole aro bekhabole nemide Drug Controller General of India (DCGI) para approval paise. Favivir toh Hetero para second drug ase. Etu agae te Covifor (Remdesivir) toh COVID-19 laga treatment nemide jolaise.
Etu toh oral anti viral medication ase aro etu para phal clinical result ola dekhaise. Favivir para mild to moderate covid symptoms thaka khan nemide phal howa toh ase.
Hetero’s Favivir laga daam toh Rs 59 per tablet te ase aro etu toh Hetero Healthcare Ltd para market kori aro manu khan ke dae.
Product toh desh laga sob retail medical outlets aro hospital pharmacies te July 29 para pai ase aro etu toh khali prescription (direction) te he bekhabo.
Add Comment